Form 4 holding
President and CEO, Director
PMV Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 451,109
- Estimated value
- $618,019
- Report date
- 27 Oct 2025
- Price
- $1.37
- Ownership
- Direct
David Henry Mack - President and CEO, Director at PMV Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- President and CEO, Director
- Issuer ticker
- PMVP on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by David Henry Mack since 28 Sep 2025
Reported holdings for David Henry Mack in PMV Pharmaceuticals, Inc.
Form 4 holding
President and CEO, Director
PMV Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 56,978
- Estimated value
- $79,769
- Report date
- 27 Oct 2025
- Price
- $1.40
- Ownership
- Indirect
Form 4 holding
President and CEO, Director
PMV Pharmaceuticals, Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 744,960
- Estimated value
- Report date
- 05 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for David Henry Mack in PMV Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.